Home Cart 0 Sign in  
X

[ CAS No. 623-50-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 623-50-7
Chemical Structure| 623-50-7
Chemical Structure| 623-50-7
Structure of 623-50-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 623-50-7 ]

Related Doc. of [ 623-50-7 ]

Alternatived Products of [ 623-50-7 ]

Product Details of [ 623-50-7 ]

CAS No. :623-50-7 MDL No. :MFCD00021970
Formula : C4H8O3 Boiling Point : -
Linear Structure Formula :- InChI Key :ZANNOFHADGWOLI-UHFFFAOYSA-N
M.W : 104.10 Pubchem ID :12184
Synonyms :

Calculated chemistry of [ 623-50-7 ]

Physicochemical Properties

Num. heavy atoms : 7
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.75
Num. rotatable bonds : 3
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 23.79
TPSA : 46.53 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.06 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.36
Log Po/w (XLOGP3) : -0.17
Log Po/w (WLOGP) : -0.46
Log Po/w (MLOGP) : -0.39
Log Po/w (SILICOS-IT) : -0.17
Consensus Log Po/w : 0.03

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.18
Solubility : 68.7 mg/ml ; 0.66 mol/l
Class : Very soluble
Log S (Ali) : -0.35
Solubility : 46.3 mg/ml ; 0.445 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -0.12
Solubility : 79.2 mg/ml ; 0.76 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.2

Safety of [ 623-50-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 623-50-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 623-50-7 ]
  • Downstream synthetic route of [ 623-50-7 ]

[ 623-50-7 ] Synthesis Path-Upstream   1~17

  • 1
  • [ 623-50-7 ]
  • [ 113-00-8 ]
  • [ 17816-85-2 ]
Reference: [1] Chemische Berichte, 1913, vol. 46, p. 2083
  • 2
  • [ 623-50-7 ]
  • [ 95-54-5 ]
  • [ 4856-97-7 ]
Reference: [1] Chinese Chemical Letters, 2010, vol. 21, # 5, p. 519 - 523
  • 3
  • [ 623-50-7 ]
  • [ 615-28-1 ]
  • [ 4856-97-7 ]
Reference: [1] Synthetic Communications, 2006, vol. 36, # 18, p. 2597 - 2601
  • 4
  • [ 110-87-2 ]
  • [ 623-50-7 ]
  • [ 61675-94-3 ]
YieldReaction ConditionsOperation in experiment
99% With toluene-4-sulfonic acid In toluene at 25℃; for 1 h; To a solution of ethyl glycolate (10 g, 0.0961 mol) in toluene (100 mL) was added 3,4- dihydro-2H-pyran ( 8 g, 0.096 1 mol) followed by catalytic amount of pTSA (30 mg) and stirred at 25 °C for 1 h. After completion of the reaction, the reaction mixture was washed with water and brine solution. The organic layer was dried over anhydrous Na2504, filtered and concentrated under reduced pressure to get 18 g (99 percent) ethyl 2-((tetrahydro-2H-pyran-2- yl)oxy)acetate, 2, as colorless liquid
94.7% at 20℃; Industrial scale Example 1.2Ethyl(tetrahydropyran-2-yloxy)-acetate (B) 100.00 kg (960.52 mol) ethyl glycolate (A) were dissolved in 180.0 L toluene and 365.22 g (1.92 mol) 4-toluenesulphonic acid monohydrate were added. At 20° C. a solution of 80.80 kg (960.52 mol) 3,4-dihydro-2H-pyran was added dropwise to the reaction mixture obtained and then the mixture was washed with 20.0 L toluene. The reaction mixture was stirred for 1 hour at 20° C. and after the reaction was complete it was combined with 100.0 L water and 6.53 kg (96.05 mol) ammonia solution (25percent). After phase separation the organic phase was washed with 100.0 L water and then the solvent was distilled off completely in vacuo.Yield: 188.4 kg (94.7percent of theory)
91.5% at 20℃; To a stirred solution of ethyl glycolate (35.3 g, 0.339 mol) containing a few crystals of p-toluene sulfonic acid, 3,4-dihydropyran (30.0 g, 0.357 mol) was added dropwise (15 g over one hour followed by 15 g over 30 min). After stirring overnight at room temperature, the mixture was diluted with diethyl ether (80 mL) and washed with a NaHCO3 solution (from 30 mL sat. NaHCO3 and 10 mL water). The organic layer was separated and dried (Na2504) followed by evaporation of the ether. The residue was distilled under high vacuum to give 58.4 g (91.5percent) of 28 as a clear liquid. 1H NMR (CDCl3, 400 MHz)δ: 1.29 (t, 3H, J=7.1 Hz, CH3), 1.53-1.95 (m, 6H, 3,4,5-THP-CH2's), 3.50-3.55 (m, 1H, 6-THP-CH2), 3.83-3.89 (m, 1H, 6-THP-CH2), 4.19 (s, 2H, OCH2CO2R), 4.20 (t, 2H, J=7.1 Hz, CH2Me), 4.75 (m, 1H, THP-CH). 13C NMR (CDCl3, 100 MHz) δ: 14.1, 18.7, 25.2, 30.0, 60.7, 61.9, 63.8, 170.4.
91.5% at 20℃; (1) Preparation of tetrahydropyran-2-yloxy-acetic acid ethyl ester (Formula 28, Scheme 4)[0378] To a stirred solution of ethyl glycolate (35.3g, 0.339mol) containing a few crystals of />toluene sulfonic acid, 3,4-dihydropyran (30.Og, 0.357mol) was added1 1 <n="113"/>dropwise (15g over one hour followed by 15g over 30min). After stirring overnight at room temperature, the mixture was diluted with diethyl ether (8OmL) and washed with a NaHCO3 solution (from 3OmL sat. NaHCO3 and 1OmL water). The organic layer was separated and dried (Na2SO4) followed by evaporation of the ether. The residue was distilled under high vacuum to give 58.4g (91.5percent) of 28 as a clear liquid. 1H NMR (CDCL3, 400MHz)δ: 1.29 (t, 3H, J = 7.1 Hz, CH3), 1.53 -1.95 (m, 6H, 3,4,5-THP-CH2's), 3.50-3.55 (m, IH, 6-THP-CH2), 3.83 - 3.89 (m, IH, 6-THP-CH2), 4.19 (s, 2H, OCH2CO2R), 4.20 (t, 2H, J = 7.1 Hz, CH2Me), 4.75 (m, IH, THP-CH). 13C NMR (CDCl3, 100MHz) δ: 14.1, 18.7, 25.2, 30.0, 60.7, 61.9, 63.8, 170.4.
81% With pyridinium p-toluenesulfonate In dichloromethane Step 1) ethyl 2-(tetrahydro-2H-pyran-2-yloxy)acetate
To a mixture of ethyl 2-hydroxyacetate (2 g, 20 mmol, Aldrich) and 3,4-dihydro-2H-pyran (3.2 g, 40 mmol, Alfa) in 40 mL of CH2Cl2 was added PPTS (500 mg, 2 mmol) slowly at rt.
The mixture was stirred at rt for 4 hours, and then the mixture was washed with brine (20 mL*2), the combined organic phases were dried over Na2SO4 and concentrated in vacuo.
The residue was purified by a silica gel column chromatography (PE: EtOAc=20:1) to give colorless oil (3.01 g, 81percent).
1H NMR (400 MHz, CDCl3): δ 1.22-1.38 (m, 4H), 1.55-1.63 (m, 3H), 1.69-1.88 (m, 3H), 3.50-3.53 (m, 1H), 3.82-3.88 (m, 1H), 4.18-4.23 (m, 4H), 4.73-4.74 (t, J=4 Hz, 1H).
81% With pyridinium p-toluenesulfonate In dichloromethane at 20℃; for 4 h; To a mixture of ethyl 2-hydroxyacetate (2 g, 20 mmol, Aldrich) and 3,4-dihydro-2H-pyran (3.2 g, 40 mmol, Alfa) in 40 mL of CH2Cl2 was added PPTS (500 mg, 2 mmol) slowly at rt.
The mixture was stirred at rt for 4 hours, and then the mixture was washed with brine (20 mLx2), the combined organic phases were dried over Na2SO4 and concentrated in vacuo.
The residure was purified by a silica gel column chromatography (PE: EtOAc =20:1) to give colorless oil (3.01 g, 81 percent).
1H NMR (400MHz, CDCl3): δ 1.22 - 1.38 (m, 4H), 1.55 - 1.63 (m, 3H), 1.69 - 1.88 (m, 3H), 3.50 - 3.53 (m, 1H), 3.82 - 3.88 (m, 1H), 4.18 - 4.23 (m, 4H), 4.73 - 4.74 (t, J=4Hz, 1H).
81% With pyridinium p-toluenesulfonate In dichloromethane at 20℃; for 4 h; Inert atmosphere To a mixture of ethyl 2 -hydroxy acetate (2 g, 20 mmol, TCI) and 3,4- dihydro-2H-pyran (3.2 g, 40 mmol, Alfa) in 40 mL Of CH2Cl2 was added PPTS (500 mg, 2 mmol, Aldrich) in portions at rt. The mixture was stirred at rt for 4 hours. The reaction mixture was then washed with brine, and the organic layer was separated and the combined organic phases were dried over Na2SO4, concentrated in vacuo. The residue was purified by a silica gel column chromatography (20: 1 (v/v) petroleum ether / EtOAc) to give the desired compound as colorless oil (3.01 g, 81 percent ).1H NMR (400MHz, CDCl3): δ 1.25 - 1.32 (m, 3H), 1.55 - 1.63 (m, 3H), 1.69 - 1.88 (m, 3H), 3.50 - 3.53 (m, IH), 3.82 - 3.88 (m, IH), 4.18 - 4.23 (m, 4H), 4.73 (t, J=3.2Hz, IH).
58% With toluene-4-sulfonic acid In toluene at 20℃; Step 1
Preparation of ethyl 2-(tetrahydro-2H-pyran-2-yloxy)acetate
A mixture of 3,4-dihydro-2H-pyran (20.4 g, 242.3 mmol), ethyl 2-hydroxyacetate (24.0 g, 230.8 mmol) and TsOH (0.794 g, 4.6 mmol) in toluene (150 mL) was stirred at room temperature overnight.
The resulting mixture was concentrated in vacuo and the residue was purified by column chromatography on silica gel (2percent EtOAc in petroleum ether) to afford ethyl 2-(tetrahydro-2H-pyran-2-yloxy)acetate (25.2 g, 58percent) as a colorless oil.

Reference: [1] Patent: WO2017/83431, 2017, A2, . Location in patent: Paragraph 00216; 00217
[2] Patent: US2011/87021, 2011, A1, . Location in patent: Page/Page column 11
[3] Patent: US2005/8570, 2005, A1, . Location in patent: Page/Page column 45
[4] Patent: WO2007/121453, 2007, A2, . Location in patent: Page/Page column 111; 112
[5] Patent: US2010/239576, 2010, A1,
[6] Patent: EP2408300, 2016, B1, . Location in patent: Paragraph 0343
[7] Patent: WO2010/45095, 2010, A1, . Location in patent: Page/Page column 76
[8] Patent: US2016/168090, 2016, A1, . Location in patent: Paragraph 0348-0349
[9] Journal of the Chemical Society, 1956, p. 2124,2126
[10] Journal of the Chemical Society, 1956, p. 4665
[11] Patent: WO2008/128961, 2008, A1, . Location in patent: Page/Page column 107
  • 5
  • [ 142-68-7 ]
  • [ 623-50-7 ]
  • [ 61675-94-3 ]
YieldReaction ConditionsOperation in experiment
32 g at 20℃; EXAMPLE 1422-((l-(2-(3-Fluoro-6-methoxy-l,5-naphthyridin-4-yl)ethyl)-2- oxabicyclo[2.2.2]octan-4-ylamino)methyl)-6H-pyrimido[5,4-b][l,4]oxazin-7(8H)-oneStep 1Ethyl 2-(Tetrahydro-2H-pyran-2-yloxy)acetateTo a stirred solution of ethyl hydroxyacetate (35.3 g) containing a few crystals of p-toluene sulfonic acid, dihydropyran (30.0 g) was added dropwise. After stirring overnight at room temperature, the mixture was diluted with dichloromethane (200 mL) and washed with a sodium hydrogencarbonate solution. The organic layer was separated and dried followed by evaporation of the dichloromethane. The residue was distilled under high vacuum to give the title compound (32 g) as a clear liquid.1H NMR (CDC13): δ 1.20-1.32 (m, 3H), 1.50-1.58 (m, 3H), 1.70-1.92 (m, 3H), 3.45-3.55 (m, 1H), 3.80-3.90 (m, 1H), 4.16-4.24 (m, 4H), 4.70-4.79 (m, 1H).
Reference: [1] Patent: WO2013/3383, 2013, A1, . Location in patent: Page/Page column 287-288
  • 6
  • [ 623-50-7 ]
  • [ 3530-14-1 ]
YieldReaction ConditionsOperation in experiment
85% With hydrazine hydrate In methanol; water at 20℃; for 5 h; Cooling with ice General procedure: To a stirred solution of esters 2a–2j (70 mmol) in MeOH (30 mL) cooled in an ice-water bath was added dropwise 80percent aqueous hydrazine hydrate (6.26 g, 100 mmol). The resulting solution was stirred at room temperature (2a–2b or 2d–2j), or reflux (2c), until the completion of reaction as indicated by TLC analysis (typically within 5 h). The reaction mixture was evaporated on a rotary evaporator to give a residue, which was purified by column chromatography through a short silica gel column to yield 3a–3k after trituration with n-hexane if possible.
81% With hydrazine In ethanol at 85℃; for 3 h; A. 2-Hydroxyacetohydrazide. A solution of ethyl 2-hydroxyacetate ( 1.00 g, 9.60 mmol), hydrazine (0.324 mg, 10.1 mmol), and ethanol (20 mL) were combined and heated to 85 °C for 3 h. The reaction was concentrated to afford the title compound (0.702 g, 81percent). MS (ESI) m/z 91.1 [M+ 1]+.
Reference: [1] Molecules, 2016, vol. 21, # 11,
[2] Patent: WO2008/51493, 2008, A2, . Location in patent: Page/Page column 196
[3] Chemical Biology and Drug Design, 2016, vol. 88, # 6, p. 873 - 883
[4] Patent: WO2011/77098, 2011, A1, . Location in patent: Page/Page column 150
[5] Combinatorial Chemistry and High Throughput Screening, 2011, vol. 14, # 2, p. 132 - 137
  • 7
  • [ 13754-19-3 ]
  • [ 623-50-7 ]
  • [ 934-33-8 ]
Reference: [1] Patent: US5624935, 1997, A,
  • 8
  • [ 623-50-7 ]
  • [ 292638-85-8 ]
  • [ 57595-23-0 ]
Reference: [1] Patent: US2006/9451, 2006, A1, . Location in patent: Page/Page column 19
  • 9
  • [ 623-50-7 ]
  • [ 100-39-0 ]
  • [ 32122-09-1 ]
YieldReaction ConditionsOperation in experiment
73% With tetra-(n-butyl)ammonium iodide; sodium hydride In tetrahydrofuran; mineral oil at 0 - 20℃; for 12.5 h; Inert atmosphere Synthesis of compound 24To the solution of hydroxy-acetic acid ethyl ester 23 (99.6g, 0.96mol) in TH F (1 .5L) under nitrogen atmosphere, NaH (42g, I .Omol: 60percent in mineral oil) was added at 0°C in portions. The mixture was stirred at 0°C for 30 min and tetrabutylammonium iodide (35.3g, O.I Omol) and benzyl bromide (163.6g, 0.96mol) were added. The mixture was allowed to warm up to r.t and was stirred in this temperature for 12h. The reaction mixture was diluted with water and extracted with ethyl acetate. The organic layer was dried over MgSC , solvent was evaporated under high vacuum and raw product was destilled (121 °C /4mBar) to give compound 24 (135.5 g, yield: 73percent). 1H-NMR (CDC ): δ= 7.41 - 7.22 (m, 5H), 4.65 (s, 2H), 4.27 (q, 2H), 4.1 1 (s, 2H), 1.25 (t, 3H).
73%
Stage #1: With sodium hydride In tetrahydrofuran; mineral oil at 0℃; for 0.5 h; Inert atmosphere
Stage #2: With tetra-(n-butyl)ammonium iodide In tetrahydrofuran; mineral oil at 0 - 20℃; for 12 h;
To the solution of hydroxy-acetic acid ethyl ester 22 (99.6 g, 0.96 mol) in THF (1 .5L) under nitrogen atmosphere, NaH (42.0 g, 1.0 mol: 60percent in mineral oil) was added at 0°C in portions. The mixture was stirred at 0°C for 30 min and tetrabutylammonium iodide (35.3 g, 0.10 mol) and benzyl bromide (163.6 g, 0.96 mol) were added. The mix- ture was allowed to warm up to room temperature and was stirred in this temperature for 12h. The reaction mixture was diluted with water and extracted with ethyl acetate. The organic layer was dried over MgSC , solventwas evaporated under high vacuum and raw product was destilled (121 °C /4 mBar) to give compound 23 (135.5 g, yield: 73percent). H-NMR (CDCIs): δ= 7.41 - 7.22 (m, 5H), 4.65 (s, 2H), 4.27 (q, 2H), 4.1 1 (s, 2H), 1 .25 (t, 3H).
57%
Stage #1: With tetra-(n-butyl)ammonium iodide; sodium hydride In tetrahydrofuran; mineral oil at 0℃; for 0.5 h;
Stage #2: at 20℃;
To a stirred and cooled (0 °C) solution of ethyl 2-hydroxyacetate (20.0 g, 19.0 mmol) in tetrahydrofuran (250 mL) was added tetrabutylammonium iodide (7.01 g, 19.0 mmol) and sodium hydride (60percent in mineral oil, 7.60 g, 19.0 mmol). The mixture was stirred at 0 °C for 30 minutes before adding benzyl bromide (32.3 g, 19.0 mmol). The reaction was stirred overnight and allowed to warm to room temperature. The mixture was then cooled (0 °C), quenched with aqueous ammonium chloride (100 mL) and extracted with ethyl acetate. The combined organic layers were washed with water and brine, dried (Na2S04) and concentrated. The residue was purified by flash chromatography over silica using a hexane/ethyl acetate eluant to afford ethyl 2- (benzyloxy)acetate as a yellow oil (14.7 g, 57percent). To a stirred and cooled (0 °C) solution of this product (13.6 g, 70.0 mmol) in tetrahydrofuran (150 mL) was added dimethyl methylphosphonate (11.3 g, 91.1 mmol) followed by a 2.0 M solution of lithium diisopropylamide in tetrahydrofuran/heptane/ethylbenzene (74.0 mL, 148 mmol). The reaction was stirred at 0 °C for 3 hours before quenching with enough 5.0 M aqueous hydrochloric acid to bring the pH to ~4. The resulting mixture was then extracted with ethyl acetate. The combined organic layers were washed with brine, dried (Na2S04) and concentrated. The residue was purified by flash chromatography over silica using a hexane/ethyl acetate eluant to afford dimethyl (3-(benzyloxy)-2-oxopropyl)phosphonate as a light yellow oil (10.1 g, 54percent). To a stirred and cooled (0 °C) solution of this intermediate (9.89 g, 36.4 mmol) in tetrahydrofuran (100 mL) was added sodium hydride (60percent in mineral oil; 1.60 g, 40.0 mmol). The mixture was stirred at 0 °C for 30 minutes before adding, dropwise, a solution of tert-butyl 4-oxo-piperidine-l-carboxylate (5.79 g, 29.1 mmol) in tetrahydrofuran (50 mL). The resulting mixture was stirred at 0 °C for 2 hours, then quenched with saturated aqueous ammonium chloride and extracted with ethyl acetate. The combined organic layers were washed with brine, dried (Na2S04), and concentrated. The residue was purified by flash chromatography over silica using a hexane/ethyl acetate eluant to afford tert-butyl 4-(3-(benzyloxy)-2- oxopropylidene)piperidine-l-carboxylate as a light yellow oil (6.50 g, 52percent). This material (6.50 g, 18.8 mmol), 10percent Pd/C (1.00 g) and ethyl acetate (50 mL) were placed in a Parr bottle and hydrogenated for 5 hours at room temperature. The mixture was filtered through Celite and concentrated to afford tert-butyl 4-(3-hydroxy-2- oxopropyl)piperidine-l-carboxylate as a yellow oil (4.80 g, 99percent). To a stirred solution of this product (4.80 g, 18.7 mmol) in methylene chloride (8 mL) was added carbon tetrabromide (12.4 g, 37.4 mmol) and triphenylphosphine (9.80 g, 37.4 mmol). After 3 hours, the reaction was concentrated and the residue purified by flash chromatography over silica using a hexane/ethyl acetate eluant to afford tert-butyl 4-(3-bromo-2- oxopropyl)piperidine-l-carboxylate as a white solid (3.30 g, 56percent). To a stirred and cooled (0 °C) solution of this product (3.30 g, 10.3 mmol) in methylene chloride (50 mL) was added trifluoroacetic acid (12.0 mL, 145 mmol). The mixture was stirred at 0 °C for 30 min before concentrating to afford crude l-bromo-3-(piperidin-4-yl)acetone trifluoroacetate, which was used without purification in the next step. To a stirred solution of diisopropylethylamine (20 mL) in acetonitrile (800 mL) at reflux was added a solution of the crude intermediate in acetonitrile (150 mL), dropwise over 4 hours (syringe pump). Reflux was continued overnight and then the mixture was concentrated. The resulting residue was partitioned between aqueous potassium carbonate solution and 9: 1 (v/v) chloroform/methanol. The organic layer was combined with a second extract using the same solvent mixture, dried (Na2S04) and concentrated. The crude material was purified flash chromatography over silica using a 95/4.5/0.5 (v/v) chloroform/methanol/ammonium hydroxide eluant to afford l-azabicyclo[3.2.2]nonan-3- one as a brown solid (770 mg, 54percent). To a stirred and cooled (0 °C) solution of this intermediate (770 mg, 5.54 mmol) in tetrahydrofuran (10 mL), was added lithium aluminum hydride (211 mg, 5.54 mmol), portion wise. After vigorous hydrogen gas evolution ceased, the reaction mixture was allowed to warm to room temperature and then heated at reflux for 1 hour. The solution was cooled to 0 °C and quenched by the successive dropwise addition of water (0.2 mL), 10percent aqueous sodium hydroxide solution (0.2 mL) and water again (0.6 mL). The colorless precipitate was removed by filtration through Celite, which was subsequently washed with tetrahydrofuran. The combined filtrate was dried (Na2S04) and concentrated to afford the title compound as yellow solid (770 mg, 99percent).
200 g With tetra-(n-butyl)ammonium iodide; sodium hydride In tetrahydrofuran; mineral oil at 0 - 25℃; for 16 h; Synthesis of Intermediate A-i. 10052] To a mixture of ethyl glycolate [623-50-7] (250.00 g, 2.40 mol), NaH (105.65 g, 2.64 mol), tetrabutylammonium iodide (THAI) (88.70 g, 240.14 mmol) in anhydrous THF (2 L) was added benzyl bromide (451.80 g, 2.64 mol) dropwise at 0° C. The resulting mixture was stirred at 25° C. for 16 hours. The reaction mixture was quenched with saturated, aqueous ammonium chloride (1 L), and the aqueous layer was extracted with ethyl acetate (3x1 L). The combined organic layers were washed with brine (1 L), dried over magnesium sulfate, the solids were removed via filtration, and the solvents of the filtrate were concentrated under reduced pressure. The residue was purified by silica gel column chromatography (petroleum ether: ethyl acetate=6: 1) to obtain intermediate A-i (200 g).10053] ‘H NMR (CDC13 400 MHz) ö ppm 7.37-7.27 (m, 5H); 4.62 (s, 2H), 4.24-4.19 (q, J=6.8 Hz, 2H); 4.07 (s, 2H);1.29-1.25 (t, J=6.8 Hz, 3H).

Reference: [1] Patent: WO2012/10633, 2012, A1, . Location in patent: Page/Page column 61-62
[2] Patent: WO2013/104561, 2013, A1, . Location in patent: Page/Page column 54; 55
[3] Tetrahedron Asymmetry, 1998, vol. 9, # 17, p. 3081 - 3094
[4] Patent: WO2014/43068, 2014, A1, . Location in patent: Page/Page column 167; 168
[5] Patent: WO2012/136834, 2012, A1, . Location in patent: Page/Page column 11
[6] Patent: US2014/45849, 2014, A1, . Location in patent: Paragraph 0051; 0052; 0053
[7] Journal of Medicinal Chemistry, 2016, vol. 59, # 17, p. 7936 - 7949
[8] Patent: WO2009/106539, 2009, A1, . Location in patent: Page/Page column 29-30
  • 10
  • [ 623-50-7 ]
  • [ 545-06-2 ]
  • [ 32122-09-1 ]
Reference: [1] Patent: US6589984, 2003, B1,
  • 11
  • [ 623-50-7 ]
  • [ 89238-99-3 ]
  • [ 88920-24-5 ]
Reference: [1] Organic Letters, 2018, vol. 20, # 15, p. 4475 - 4477
  • 12
  • [ 67443-38-3 ]
  • [ 623-50-7 ]
  • [ 105544-30-7 ]
YieldReaction ConditionsOperation in experiment
82% With sodium hydride In tetrahydrofuran at 0 - 20℃; for 1 h; Method I: 5-bromo-2-chloro-3-nitropyridine (100 mg, 0.42 mmol) and Ethyl glycolate (0.044 mL, 0.46 mmol) were dissolved in THF (5 mL) and cooled to 0°C. Sodium hydride (0.015 mL, 0.46 mmol) was added and the mixture was stirred for 1hr at room temperature. Reaction mixture was poured in ice water and extracted with EtOAc (2 x 10ml). The organiclayer was washed with brine (10ml), dried over sodium sulphate and concentrated. The crude product was purified by flash column using 100-200 silica gel to ethyl 2-(5-bromo-3-nitropyridin-2-yloxy)acetate (105 mg, 82 percent) 9(b). 1H NMR (300 MHz, DMSO-d6) δ = 1.27 (s, 3H), 4.25 (q, 2 H), 5.12 (s, 2H) 8.40 (d, J = 2.07 Hz, 1 H), 8.47 (d, J = 2.07 Hz, 1 H); ESMS: m/z 306.8 [M+1]
49%
Stage #1: With sodium hydride In 1,4-dioxane at 70℃; for 1 h;
Stage #2: at 20 - 70℃; for 17 h;
Step 1. Sodium hydride (55percent dispersion in mineral oil, 603 mg, 13.8 mmol) was added to a solution of ethyl glycolate (1.43 g, 13.8 mmol) in 1,4-dioxane, and the reaction mixture was heated at 70° C. for 1 h, then 5-bromo-2-chloro-3-nitropyridine (Eur. Pat. Appl. EP 122109 (1984); 1.64 g, 6.91 mmol) was added, and stirring was continued at 70° C. for 1 h and at room temperature for 16 h. The reaction mixture was then neutralized with sat. aq. sodium hydrogencarbonate solution and extracted three times with dichloromethane. The organic layers were pooled, dried (Na2SO4), and evaporated. Chromatography (SiO2, hexane-ethyl acetate gradient) furnished (5-bromo-3-nitro-pyridin-2-yloxy)-acetic acid ethyl ester (1.03 g, 49percent). Light yellow liquid, MS (ISP)=305.1 (M+H)+.
44%
Stage #1: With sodium hydride In 1,4-dioxane at 20 - 30℃; for 0.75 h;
Stage #2: at 0 - 80℃;
To a suspension of sodium hydride (5.31 g, 133 mmol) in 1 ,4-dioxane (250 ml), ethyl glycolate (12.56 ml, 133 mmol) was added drop wise over a period of 30 minutes ensuring that the temperature was maintained below 30°C. The resulting thick suspension was stirred at room temperature for 15 minutes. In a separate 11 round- bottomed flask was added 5-bromo-2-chloro-3-nitropyridine (21 g, 88 mmol) in 1 ,4- dioxane (150 ml) to give a brown solution. The suspension of sodium hydride and ethyl glycolate was added drop wise over a period of 30 minutes at 0°C. The resulting reaction mixture was heated to 80°C overnight. The reaction mixture was concentrated under reduced pressure and the crude residue was purified by Biotage silica chromatography (gradient 0percent to 10percent ethyl acetate in n- hexanes) to give the title compound (1 .8g, 44percent). N R (500 MHz, CDCI3): 8.48 (1 H, s), 8.42 (1 H, s), 5.07 (2H, s), 4.28-4.24 (2H, q), 1.31-1.28 (3H, t).
Reference: [1] Synthetic Communications, 2013, vol. 43, # 24, p. 3315 - 3321
[2] Patent: US2007/191603, 2007, A1, . Location in patent: Page/Page column 37
[3] Patent: WO2011/77098, 2011, A1, . Location in patent: Page/Page column 157-158
[4] Patent: WO2007/77961, 2007, A2, . Location in patent: Page/Page column 358
  • 13
  • [ 623-50-7 ]
  • [ 74877-08-0 ]
  • [ 74877-08-0 ]
  • [ 176707-77-0 ]
Reference: [1] Tetrahedron Asymmetry, 2007, vol. 18, # 11, p. 1330 - 1337
  • 14
  • [ 6602-54-6 ]
  • [ 623-50-7 ]
  • [ 371945-06-1 ]
YieldReaction ConditionsOperation in experiment
70% at 70℃; for 4 h; To a stirred mixture of the pyridine 51a (2.00 g, 1.0 eq), the alcohol 51b (1.43 mL, 1.05 eq), CuI (0.05 g, 0.02 eq) is added Cs2CO3 (10.3 g, 2.2 eq) and heated at 70° C. during4 h. The reaction mixture is cooled down to RT, poured into H2O (300 mL) and allowed to stand for 1 h until precipitation. The suspension is filtered, triturated with Et2O/Hex (1:1), dried with toluene azeotrope to give 51c (2.0 g, 70percent).
50% With caesium carbonate; 1,8-diazabicyclo[5.4.0]undec-7-ene In toluene at 80℃; for 24 h; Inert atmosphere 2- Chloro 3-pyridine carbonitrile (1, 2.0 g, 1 equiv.), Cs2C03 (14.2 g, 3 equiv.) and ethyl glycolate (1.5 mL, 1.2 equiv.) were placed in a flask under inert atmosphere. Dry toluene and DBU (4.3 mL, 2 equiv) were added and the suspension was heated at 80 °C for 24 h with vigorous stirring. The reaction mixture was cooled to RT, and then water and EtOAc were added. The organic layer was seperated and was washed with water before being dried over anhydrous Na2S04 and concentrated in vacuo. Purification was done by column chromatography on silica gel using 10-40percent EtOAC: hexane as a mobile phase to get product 2 (1.5 g, 50percent) as a white solid. *H NMR (CDC13, 400 MHz): δ 8.51 (dd, / = 5.0, 2.0 Hz, 1H), 7.96 (dd, / = 8.0, 2.0 Hz, 1H), 7.23-7.28 (m,1H), 4.44 (q, / = 7.0 Hz, 2H), 4.01 (br, s, 2H), 1.44 (t, / = 7.0 Hz, 3H); ESI-MS: nt/z 229.05 [M+Na]+
40% With caesium carbonate In 1-methyl-pyrrolidin-2-one at 75℃; for 20 h; Inert atmosphere 2-Chloro-3-pyridinecarbonitrile, 1 , (4.0Og, 28.9mmol), Cs2CO3 (28.2g, 86.6mmol) and ethyl glycolate (3mL, 31.7mmol) were placed in a flask under Ar(g). Dry NMP was added, and the suspension was heated at 75°C for 2Oh with vigorous stirring. The reaction mixture was cooled to rt, whereupon water (200 mL) and Et2ψ (3 x 10OmL) were added. The organic layers were combined, washed with water (3 x 15mL) before being dried (MgSO4) and concentrated in vacuo. Purification by flash column chromatography on silica (eluant 15-40percent EtOAc/Hex) gave 2 (2.41 g, 1 1 Jmmol, 40percent) as a white solid.1H NMR (400MHz, CDCI3) δH: 8.51 (dd, J=5.0, 2.0Hz, 1 H), 7.96 (dd, J=8.0, 2.0Hz, 1 H), 7.23-7.28 (m, 1 H), 4.44 (q, J=7.0Hz, 2H), 4.01 (br. s., 2H), 1.44 (t, J=7.0Hz, 3H).MS (ES+) 229 (100percent, [M+Na]+).
Reference: [1] Patent: US2010/261714, 2010, A1, . Location in patent: Page/Page column 75
[2] Synthesis, 2007, # 20, p. 3247 - 3251
[3] Patent: WO2017/90058, 2017, A1, . Location in patent: Page/Page column 14
[4] Patent: WO2011/21038, 2011, A1, . Location in patent: Page/Page column 18; 24
[5] ACS Medicinal Chemistry Letters, 2014, vol. 5, # 2, p. 138 - 142
[6] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 9, p. 2438 - 2442
  • 15
  • [ 623-50-7 ]
  • [ 140-88-5 ]
  • [ 89898-51-1 ]
YieldReaction ConditionsOperation in experiment
80%
Stage #1: With sodium hydride In diethyl ether at 20℃; for 0.75 h; Inert atmosphere; Cooling with ice
Stage #2: at 20℃; Cooling with ice
Step 1-Synthesis of ethyl 4-oxotetrahydrofuran-3-carboxylate (ge). NaH (60percent, 4.6 g, 116 mmol) was suspended in ether (200 mL) and cooled in ice-bath. To this suspension was added ethyl glycolate (10 mL, 100 mmol) dropwise under N2. The resulting white slurry was stirred at rt for 45 min. Ether was removed in vacuo to give white solid. It was suspended in DMSO (130 mL), cooled in ice-bath, and ethyl arcylate (13.7 mL, 127 mmol) was added dropwise. The resulting yellow mixture was stirred at rt overnight. The reaction solution was poured into 10percent aq. HCl (500 mL) slowly. It was extracted with ether (3.x.). The combined ether extract was washed with brine, dried over MgSO4, filtered, concentrated in vacuo to give 14 g (80percent) of (ge) as clear yellow liquid. It was carried on without further purification.
46%
Stage #1: With sodium hydride In diethyl ester at 20℃; for 1.5 h;
Stage #2: at 0 - 20℃; for 3 h;
Referring to the scheme immediately above, to a suspension of sodium hydride (60 percent in oil) (42.0 g, 1.05 mol) in diethyl ether (800 mL) was added ethyl glycolate (100 g, 0.96 mol) over a period of 1 hour at room temperature. The suspension was then stirred for an additional 0.5 hour and evaporated under vacuum. To the resulting solid, dimethyl sulfoxide (200 mL) was added. It was then cooled to 0 C and a solution of ethyl acrylate (115.10 g, 1.15 mol) in dimethyl sulfoxide (100 mL) was added in portions with vigorous stirring. The suspension was allowed to warm to room temperature and stirred for 3 hours. The reaction mixture was cautiously poured into ice cold aqueous solution of sulfuric acid (5 percent, 300 mL), extracted with ether (3 x 100 mL), dried over MgSO4, evaporated and chromatographed on silica gel (hexane/ethyl acetate, 10:1) to afford compound 3 (70.0 g, 46 percent). 1H NMR (400 MHz, CDCl3) δ 4.55-4.40 (m, 2H), 4.30-4.20 (m, 2H), 4.10-3.95 (m, 2H), 3.50 (t, 1H), 1.15 (t, 3H)
38%
Stage #1: With sodium hydride In tetrahydrofuran at 0 - 20℃; for 0.75 h; Inert atmosphere
Stage #2: at 0 - 20℃; for 12 h; Inert atmosphere
To a 0 oC solution of ethyl 2-hydroxyacetate 1 (5 mL, 50 mmol) in THF (100 mL) was added NaH (60percent, 2.3 g, 58 mmol) under a nitrogen atmosphere. The resulting solution was stirred at the room temperature for 45 minutes. The solvents were removed under reduced pressure. The resulting residue was suspended in dimethyl sulfoxide (65 mL) and cooled to 0°C. Ethyl acrylate (6.8 mL, 63 mmol) was then added dropwisely. The resulting solution was stirred at the room temperature for 12 hours. Then the resulting solution was slowly poured into aqueous hydrochloric acid (10percent>, 250 mL). It was extracted with diethyl ether (150 mL x 3). The combined organic layers were washed with brine, dried over sodium sulfate, filtered and concentrated to give intermediate 2 (3 g, 38percent)). which was used in the next step without further purification. LRMS (M + H+) m/z: calcd 159.15; found 159.21.
Reference: [1] Patent: US2010/331305, 2010, A1, . Location in patent: Page/Page column 80-81
[2] Patent: WO2004/26864, 2004, A1, . Location in patent: Page 129; 130
[3] Patent: WO2014/15291, 2014, A1, . Location in patent: Page/Page column 181
  • 16
  • [ 623-50-7 ]
  • [ 105942-08-3 ]
  • [ 887250-14-8 ]
Reference: [1] Patent: EP1849465, 2007, A1, . Location in patent: Page/Page column 70
  • 17
  • [ 885275-20-7 ]
  • [ 623-50-7 ]
  • [ 1060814-36-9 ]
Reference: [1] Patent: WO2012/117421, 2012, A1, . Location in patent: Page/Page column 39
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 623-50-7 ]

Aliphatic Chain Hydrocarbons

Chemical Structure| 817-95-8

[ 817-95-8 ]

Ethyl 2-ethoxyacetate

Similarity: 0.95

Chemical Structure| 96-35-5

[ 96-35-5 ]

Methyl 2-hydroxyacetate

Similarity: 0.89

Chemical Structure| 623-61-0

[ 623-61-0 ]

Isopropyl glycolate

Similarity: 0.86

Chemical Structure| 617-37-8

[ 617-37-8 ]

2-Ethoxy-2-oxoacetic acid

Similarity: 0.86

Chemical Structure| 7397-62-8

[ 7397-62-8 ]

Butyl 2-hydroxyacetate

Similarity: 0.82

Alcohols

Chemical Structure| 96-35-5

[ 96-35-5 ]

Methyl 2-hydroxyacetate

Similarity: 0.89

Chemical Structure| 623-61-0

[ 623-61-0 ]

Isopropyl glycolate

Similarity: 0.86

Chemical Structure| 7397-62-8

[ 7397-62-8 ]

Butyl 2-hydroxyacetate

Similarity: 0.82

Chemical Structure| 50595-15-8

[ 50595-15-8 ]

tert-Butyl 2-hydroxyacetate

Similarity: 0.78

Chemical Structure| 169751-72-8

[ 169751-72-8 ]

tert-Butyl 14-hydroxy-3,6,9,12-tetraoxatetradecan-1-oate

Similarity: 0.75

Esters

Chemical Structure| 817-95-8

[ 817-95-8 ]

Ethyl 2-ethoxyacetate

Similarity: 0.95

Chemical Structure| 96-35-5

[ 96-35-5 ]

Methyl 2-hydroxyacetate

Similarity: 0.89

Chemical Structure| 623-61-0

[ 623-61-0 ]

Isopropyl glycolate

Similarity: 0.86

Chemical Structure| 617-37-8

[ 617-37-8 ]

2-Ethoxy-2-oxoacetic acid

Similarity: 0.86

Chemical Structure| 7397-62-8

[ 7397-62-8 ]

Butyl 2-hydroxyacetate

Similarity: 0.82